Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02104401 · ClinicalTrials.gov registry record · Phase 1
Open Label Treatment With tDCS for Parkinson's and Related Disorders for Improvement of Speech, Gait and Mood
A Phase 1 study, sponsored by Georgetown University.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT02104401 is a Phase 1 study that has completed, run by Georgetown University. The registered enrollment target is 10 participants.
The verdict
NCT02104401, a Phase 1 study, has completed, sponsored by Georgetown University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
This research will help us to understand whether transcranial direct current stimulation (tDCS) can safely improve recovery of speech and language abilities, gait , and mood in people with Parkinson's disease and related disorders. Some of the disorders that will be studied to understand if tDCS can be useful include Parkinson's Disease, Multi-System Atrophy (MSA) and progressive supranuclear palsy (PSP).
Interventions
- DEVICE tDCS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2013-10 |
| Est. Completion | 2014-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02104401
The ClinicalTrials.gov registry entry for NCT02104401 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Georgetown University, which has 227 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which tDCS is the first listed.
NCT02104401 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02104401 about?
NCT02104401 is a clinical study titled "Open Label Treatment With tDCS for Parkinson's and Related Disorders for Improvement of Speech, Gait and Mood". This research will help us to understand whether transcranial direct current stimulation (tDCS) can safely improve recovery of speech and language abilities, gait , and mood in people with Parkinson's disease and related disorders. Some of the disorders that will be studied to understand if tDCS can...
What is the current status of trial NCT02104401?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2013-10. Estimated completion is 2014-03.
What interventions are being tested in trial NCT02104401?
The interventions under investigation include: tDCS (DEVICE).
Who is sponsoring clinical trial NCT02104401?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.